Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Post by ElChap0on Dec 04, 2018 12:45am
327 Views
Post# 29058870

uh oh

uh oh

Levi & Korsinsky announces it has commenced an investigation of Aphria, Inc. ("Aphria" or "the Company") (NYSE: APHA) concerning possible violations of federal securities laws.

To obtain additional information, go to:

https://www.zlk.com/pslra-1/aphria-inc-loss-form

or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972.
 

Bragar Eagel & Squire, P.C. is investigating potential claims against Aphria Inc. (NYSE: APHA). Our investigation concerns whether Aphria has violated the federal securities laws and/or engaged in other unlawful business practices.

On December 3, 2018, Hindenburg Research released a report titled, "Aphria: A Shell Game with a Cannabis Business on the Side." According to the report, which was also released on Seeking Alpha, "Aphria is part of a scheme orchestrated by a network of insiders to divert funds away from shareholders into their own pockets."

On this news, Aphria's share price fell by more than 24%, closing at $6.05 per share on December 3, 2018.

If you purchased or otherwise acquired Aphria shares on the New York Stock Exchange and suffered a loss, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at investigations@bespc.com, or telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.

Bragar Eagel & Squire, P.C. is a New York-based law firm concentrating in commercial and securities litigation. For additional information concerning our investigation into Aphria please go to https://www.bespc.com/apha/. For additional information about Bragar Eagel & Squire, P.C., please go to www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.
 

Scott+Scott Attorneys at Law LLP ("Scott+Scott"), a national shareholder and consumer rights litigation firm, is investigating whether Aphria, Inc. ("Aphria" or the "Company") (NYSE: APHA) or certain of its officers and directors violated federal securities laws. If you purchased Aphria stock on the New York Stock Exchange ("NYSE"), you are encouraged to contact a Scott+Scott attorney at (844) 818-6982 for more information.

Aphria is a Canadian company that produces, supplies, and sells medical marijuana.

On December 3, 2018, Hindenburg Research released a report titled, "Aphria: A Shell Game with a Cannabis Business on the Side." According to the report, which was also released on Seeking Alpha, "Aphria is part of a scheme orchestrated by a network of insiders to divert funds away from shareholders into their own pockets."

On this news, the price of Aphria stock is currently down $2.17 - over 27% - in intraday trading on the NYSE.

What You Can Do

If you purchased Aphria stock on the NYSE, and you wish to discuss this investigation, please contact attorney Joe Pettigrew at (844) 818-6982, or at jpettigrew@scott-scott.com, or visit the Aphria investigation page on our website at https://scott-scott.com/investigation/aphria-inc.

About Scott+Scott Attorneys at Law LLP

Scott+Scott has significant experience in prosecuting major securities, antitrust, and employee retirement plan actions throughout the United States. The firm represents pension funds, foundations, individuals, and other entities worldwide with offices in New York, London, Connecticut, California, and Ohio.
 

Bullboard Posts